20/03/2017 07:00:53

Alliance Trust PLC : Transaction in Own Shares

Related content
14:08 - 
Alliance Trust PLC : Net Asset Value(s)
21 Nov - 
Alliance Trust PLC : Net Asset Value(s)
20 Nov - 
Alliance Trust PLC : Net Asset Value(s)
Related debate
04 Oct - 
There is obviously a lot to know about this. I think yo..
02 Oct - 
Continue blogging. Hoping to perusing your next post bu..
28 Sep - 
This is such a great resource that you are providing an..

20 March 2017 

Alliance Trust PLC

TRANSACTION IN OWN SHARES 

The Board of Alliance Trust PLC ("the Company") announces that on 17 March 2017 the Company purchased for cancellation 2,163,248 ordinary shares of 2.5p each at a price of 694.4288p per share. 

Therefore, the total number of voting rights in the Company is now 368,399,240.

   

The above figure (368,399,240) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules. 

Enquiries: 

George Renouf

Alliance Trust PLC 

Telephone: 0131 322 3357


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Alliance Trust PLC via Globenewswire

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Dimensional Fund Advisors Ltd. : Form 8.3 - Tesco Plc - Ordinary shares

22/11/2017 10:18:00
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:   Dimensional Fund Advisors Ltd. ("Dimensional"), in its capacity ..

Majedie Asset Management Ltd : Form 8.3 - TESCO PLC

21/11/2017 15:35:27
FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser: ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
ARRAY BIOPHARMA LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Array Biopharma, Inc. To Contact The Firm
2
Sprouts Farmers Market to Present at the Barclays 2017 Eat, Sleep, Play – It’s Not All Discretionary Conference
3
Franklin Electric Launches Four New Key Dealer Tutorial Videos To Help Contractors Maximize Program Value
4
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Ford Motor Company – F
5
Portola Pharmaceuticals Provides Update on Bevyxxa® (betrixaban) Commercial Launch

Related stock quotes

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 November 2017 20:23:04
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20171108.1 - EUROWEB2 - 2017-11-22 21:23:04 - 2017-11-22 20:23:04 - 1000 - Website: OKAY